Manulife (Manufacturers Life Insurance)’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$534K Buy
+23,747
New +$440K ﹤0.01% 2130
2025
Q1
Sell
-62,391
Closed -$264K 2998
2024
Q4
$264K Sell
62,391
-3,414
-5% -$21.3K ﹤0.01% 2508
2024
Q3
$753K Buy
65,805
+30,135
+84% +$369K ﹤0.01% 2065
2024
Q2
$381K Hold
35,670
﹤0.01% 2318
2024
Q1
$548K Buy
+35,670
New +$558K ﹤0.01% 2176

Other funds holding ANRO

Manulife (Manufacturers Life Insurance)'s ANRO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 23,747 shares worth $534K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in ANRO as recently as Q4 2024.

Manulife (Manufacturers Life Insurance) first reported a position in ANRO in Q1 2024 and has held it in 5 quarters since. The position peaked at $753K in Q3 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 23,747 shares of Alto Neuroscience worth $534K as of Q1 2026.
  • Alto Neuroscience was a new Manulife (Manufacturers Life Insurance) position in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2130 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Alto Neuroscience in Q1 2024 and has held it in 5 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Alto Neuroscience position peaked at $753K in Q3 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.